≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Congenital malformations of trachea and bronchus

EFO Endpoint Browser PheWeb

Q17_CONGEN_MALFO_TRACHEA_BRONCHUS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q32
  • Cause of death: ICD-10 — Q32

2 out of 7 registries used, show all original rules.

344

4. Check minimum number of events

None

344

5. Include endpoints

None

344

6. Filter based on genotype QC (FinnGen only)

339

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_RESPI_SYSTEM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q3[0-4]
Name in latin
Malformationes congenitae tracheae et bronchorum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2594 1354 1230
Only index persons 2115 1173 942
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.03
Only index persons 0.04 0.04 0.04
Median age at first event (years)
Whole population 44.83 59.59 28.36
Only index persons 55.76 60.59 49.76

-FinnGen-

Key figures

All Female Male
Number of individuals 339 215 124
Unadjusted period prevalence (%) 0.07 0.08 0.06
Median age at first event (years) 60.16 59.65 61.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
344
Matched controls
3440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UGC12
NOMESCO Finland
Flexible bronchoscopy
34.1
248.6
201
136
Q32.21
ICD-10 Finland
Secondary congenital bronchomalacia
3294.1
194.0
169
*
Q32.0
ICD-10 Finland
Congenital tracheomalacia
+∞
124.8
112
*
R03BB04
ATC
tiotropium bromide; inhalant
11.7
102.4
133
176
R03AK06
ATC
salmeterol and fluticasone; inhalant
7.6
73.4
143
293
J45.9
ICD-10 Finland
Asthma, unspecified
7.1
72.9
174
436
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
11.0
71.1
87
103
J46
ICD-10 Finland
Status asthmaticus
20.3
68.4
55
32
R03DC03
ATC
montelukast; oral
6.3
61.0
147
363
J45.1
ICD-10 Finland
Nonallergic asthma
7.8
59.0
99
170
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.7
55.3
159
454
J47
ICD-10 Finland
Bronchiectasis
17.7
53.0
45
29
R03BA05
ATC
fluticasone; inhalant
5.3
50.3
154
458
R03BA08
ATC
ciclesonide; inhalant
7.6
49.9
82
136
R03AC02
ATC
salbutamol; inhalant
8.0
49.7
297
1514
XG410
NOMESCO Finland
Flow-volume spirometry
11.0
49.4
57
61
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
97.3
46.3
50
6
Q32.20
ICD-10 Finland
Congenital bronchomalacia
+∞
45.9
43
*
R03DA04
ATC
theophylline; systemic, rectal
9.2
45.3
60
77
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
13.9
45.3
44
36
WX704
NOMESCO Finland
Intubation
8.0
45.2
69
105
R05
ICD-10 Finland
Cough
4.8
44.4
155
504
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.5
42.3
166
587
R06.0
ICD-10 Finland
Dyspnoea
4.5
41.9
172
628
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.4
40.4
52
64
R03AK08
ATC
formoterol and beclometasone; inhalant
8.8
39.8
54
71
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.8
39.7
87
190
WX725
NOMESCO Finland
Noninvasive ventilation
8.4
38.0
54
75
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
11.3
37.9
42
42
H02AB06
ATC
prednisolone; systemic
4.3
36.6
238
1173
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
9.8
36.6
45
52
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
5.7
36.5
80
174
J45.8
ICD-10 Finland
Mixed asthma
9.7
35.7
44
51
R03BB01
ATC
ipratropium bromide; inhalant
8.5
35.3
49
66
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
6.0
35.1
71
143
G47.3
ICD-10 Finland
Sleep apnoea
4.1
33.5
129
438
R96
ICPC
Asthma
5.2
32.7
78
182
R03BC03
ATC
nedocromil; inhalant
5.8
31.5
65
133
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.0
31.2
124
427
R02
ICPC
Shortness of breath/dyspnoea
4.5
30.0
91
257
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.1
29.1
47
75
TPH04
NOMESCO Finland
Cathetrisation of vein
3.7
28.5
128
475
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
28.2
221
1159
R03BA02
ATC
budesonide; inhalant
3.8
28.1
116
407
R03AC12
ATC
salmeterol; inhalant
6.5
27.6
49
86
Z01.8
ICD-10 Finland
Other specified special examinations
3.6
27.3
126
474
J01MA14
ATC
moxifloxacin; systemic
5.0
26.2
64
151
R03AK07
ATC
formoterol and budesonide; inhalant
3.6
25.3
112
408
R03BA01
ATC
beclometasone; inhalant
4.0
23.8
82
251
WX892
NOMESCO Finland
Monitored bed care
4.9
23.8
58
136
R05
ICPC
Cough
3.2
23.3
139
603
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.5
23.0
99
352
R03AC13
ATC
formoterol; inhalant
5.9
23.0
44
83
R04.2
ICD-10 Finland
Haemoptysis
8.2
22.4
31
41
GD1AD
NOMESCO Finland
Thorax CT examination
5.8
22.4
44
85
UGC02
NOMESCO Finland
Rigid bronchoscopy
67.1
22.2
25
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.9
21.2
51
118
R03AK11
ATC
formoterol and fluticasone; inhalant
8.2
21.1
29
38
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.9
21.0
34
54
R03AC03
ATC
terbutaline; inhalant
3.6
20.8
82
274
UDQ12
NOMESCO Finland
Flexible laryngoscopy
5.3
20.5
44
92
R06.2
ICD-10 Finland
Wheezing
5.3
19.8
43
91
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.5
18.9
28
40
C03CA01
ATC
furosemide; systemic
2.8
18.3
146
724
WX720
NOMESCO Finland
Own respiration
6.0
18.3
34
62
J01FA06
ATC
roxithromycin; oral
2.7
18.3
173
936
SPAT1263
SPAT
Sampling
2.7
18.2
185
1037
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
19.4
18.1
27
15
Q32.10
ICD-10 Finland
Other congenital malformations of trachea
+∞
17.9
17
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.7
17.4
34
65
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
5.6
17.1
34
66
A02BC05
ATC
esomeprazole; systemic
2.6
16.9
172
954
Q32.4
ICD-10 Finland
Other congenital malformations of bronchus
+∞
16.8
16
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.7
16.7
41
96
R03AK03
ATC
[U] fenoterol and ipratropium bromide
4.9
16.6
39
88
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.7
16.5
41
97
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
6.9
16.4
26
40
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
16.4
86
338
SPAT1059
SPAT
Spirometry at the office
4.7
15.9
39
91
H02AB04
ATC
methylprednisolone; systemic
3.1
15.9
78
295
R01AD58
ATC
fluticasone, combinations; nasal
2.8
15.6
103
458
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.0
15.4
47
130
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
14.9
220
1424
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
26.4
14.9
20
8
TDM10
NOMESCO Finland
Puncture of maxillary antrum
6.0
14.9
27
48
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.1
14.6
43
116
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
18.0
14.5
22
13
TGC00
NOMESCO Finland
Bronchial lavation
6.5
14.4
24
39
N03AX16
ATC
[U] pregabalin
2.6
14.3
109
519
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.6
14.2
51
158
SPAT1081
SPAT
Cardiorespiratory global assessment
4.7
14.1
34
78
WX402
NOMESCO Finland
General anaesthesia
2.6
14.0
101
467
J45
ICD-10 Finland
Asthma
3.3
13.9
58
198
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
13.9
64
232
SPAT1301
SPAT
No procedures
2.4
13.6
137
739
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.9
13.6
25
45
J01MA12
ATC
levofloxacin; systemic
2.7
13.5
86
373
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
13.1
127
672
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.3
12.6
167
1007
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
12.4
118
617
AA1AD
NOMESCO Finland
CT of head and brain
2.4
12.3
115
595
H02AB07
ATC
prednisone; oral
2.9
12.3
66
260
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
12.2
62
237
J01FA10
ATC
azithromycin; systemic
2.3
12.2
227
1566
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
11.9
42
128
WX722
NOMESCO Finland
PEEP
4.2
11.9
33
85
SPAT1058
SPAT
PEF monitoring instruction
3.4
11.8
47
155
J42
ICD-10 Finland
Unspecified chronic bronchitis
17.2
11.8
18
11
R95
ICPC
Chron obstructive pulmonary disease
6.0
11.6
21
37
R01AD08
ATC
fluticasone; nasal
2.3
11.6
114
601
R01AD09
ATC
mometasone; nasal
2.2
11.6
173
1083
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.5
11.6
91
434
R49.08
ICD-10 Finland
Other specified dysphonia
5.8
11.3
21
38
R06.5
ICD-10 Finland
Mouth breathing
3.2
11.2
47
160
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
4.1
11.2
32
84
R99
ICPC
Respiratory disease other
9.3
10.9
22
25
R04
ICPC
Breathing problem other
4.7
10.9
26
59
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.4
10.7
93
463
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
10.6
74
333
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.4
10.6
27
65
Q32.11
ICD-10 Finland
Congenital tracheo-esophageal fissure
+∞
10.5
10
*
H02AB09
ATC
hydrocortisone; systemic
5.2
10.4
22
45
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.2
10.4
125
712
J01AA02
ATC
doxycycline; systemic
2.4
10.3
270
2073
N06AA09
ATC
amitriptyline; systemic
3.0
10.3
49
180
WX872
NOMESCO Finland
Intensive care
4.4
10.1
26
63
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
10.0
79
375
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
5.1
9.9
21
43
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
9.9
67
296
SPAT1262
SPAT
Handing over of treatment supplies
2.5
9.9
73
336
R06.1
ICD-10 Finland
Stridor
26.9
9.9
13
5
R51.80
ICD-10 Finland
Headache
2.5
9.9
75
350
5191A
ICD-9 Finland
Other diseases of respiratory system, Other diseases of trachea and bronchus, not elsewhere classified
56.6
9.7
11
*
C08CA01
ATC
amlodipine; oral
2.1
9.7
145
893
I50.9
ICD-10 Finland
Heart failure, unspecified
2.6
9.6
65
287
C01DA14
ATC
isosorbide mononitrate; oral
2.5
9.5
67
301
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
18.2
9.5
14
8
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
12.8
9.5
16
13
R28
ICPC
Limited function/disability (R)
12.8
9.5
16
13
-1, ,
ICPC
4.1
9.3
26
67
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
9.3
83
416
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
9.1
185
1263
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.4
9.1
23
55
A01AB09
ATC
miconazole; local oral
2.8
8.9
48
188
C07AB07
ATC
bisoprolol; oral
2.0
8.9
179
1215
UJF32
NOMESCO Finland
Coloscopy
2.1
8.9
105
588
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
8.8
75
367
B01AB05
ATC
enoxaparin; parenteral
2.1
8.8
122
726
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
5.0
8.7
19
40
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
8.6
8.7
18
22
J96.1
ICD-10 Finland
Chronic respiratory failure
7.3
8.7
20
29
SPAT1260
SPAT
Consultation of another employee
2.3
8.7
79
398
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
8.5
152
985
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
28.3
8.5
11
*
E66.01
ICD-10 Finland
Obesity due to excess calories
3.0
8.5
39
140
A06AD11
ATC
lactulose; oral
2.4
8.5
63
290
J41.0
ICD-10 Finland
Simple chronic bronchitis
13.2
8.4
14
11
I50.0
ICD-10 Finland
Congestive heart failure
3.0
8.4
38
135
N03AX12
ATC
[U] gabapentin; oral
2.3
8.4
71
346
GBA32
NOMESCO Finland
Endoscopic dilatation of trachea
+∞
8.4
8
*
GCA18
NOMESCO Finland
Bronchoscopic dilatation of bronchus
+∞
8.4
8
*
Z93.0
ICD-10 Finland
Tracheostomy status
+∞
8.4
8
*
81
HP
Angiography of the heart and coronary arteries
3.4
8.3
31
98
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
7.9
8.3
18
24
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.6
8.3
20
46
SPAT1360
SPAT
Extensive global examination
3.3
8.2
32
104
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
4.2
8.2
22
55
B01AA03
ATC
warfarin; systemic
2.3
8.2
76
385
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.2
8.2
34
115
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.7
8.0
45
180
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.7
8.0
46
187
XQ845
NOMESCO Finland
Dermatoscopy
8.1
8.0
17
22
A28
ICPC
Limited function/disability NOS
2.2
8.0
75
382
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
8.0
56
251
XG405
NOMESCO Finland
Education on PEF monitoring
8.8
7.9
16
19
R01AD12
ATC
fluticasone furoate; nasal
2.0
7.9
110
652
J01MA02
ATC
ciprofloxacin; systemic
1.9
7.8
140
903
-31
ICPC
Medical examin/health eval partial
3.1
7.8
33
113
UDM02
NOMESCO Finland
Sinoscopy
7.7
7.8
17
23
R5140
NOMESCO Finland
Monitoring the use of the aid
2.6
7.7
50
215
205
Kela drug reimbursment
Chronic hypertension
2.0
7.7
99
569
J01CA04
ATC
amoxicillin; systemic
2.4
7.7
295
2460
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
7.6
100
579
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
7.6
49
211
N06AX11
ATC
mirtazapine; oral
1.9
7.5
126
792
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
7.5
42
168
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
7.4
46
194
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.6
7.4
45
188
UDQ02
NOMESCO Finland
Direct laryngoscopy
11.2
7.4
13
12
A01AB04
ATC
amphotericin B; local oral
3.2
7.4
29
95
Q32.18
ICD-10 Finland
Other congenital malformations of trachea
+∞
7.3
7
*
RF210, ,
NOMESCO Finland
4.5
7.3
18
42
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
7.2
91
517
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
7.2
91
517
SPAT1229
SPAT
Assessment of need for aid
2.9
7.2
34
124
7862A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Cough
12.4
7.1
12
10
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
7.1
107
647
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.0
7.1
97
567
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
7.2
7.1
16
23
SPAT1097
SPAT
Recording of ECG
2.3
7.1
59
285
AN1
HP
Coronary angiography
2.5
7.0
46
199
R29
ICPC
Respiratory symptom/complaint other
2.9
7.0
33
120
R49.01
ICD-10 Finland
Functional dysphonia
4.1
7.0
19
48
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
7.0
99
586
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
7.0
36
138
XG466
NOMESCO Finland
Sleep oxymetry
4.3
6.9
18
44
L28
ICPC
Limited function/disability (L)
2.1
6.8
74
397
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
6.7
32
117
N06AX21
ATC
duloxetine; oral
2.4
6.7
49
223
R81
ICPC
Pneumonia
4.2
6.7
18
45
H3603, E103,
ICD-10 Finland
23.0
6.7
9
*
N05CF01
ATC
zopiclone; oral
1.9
6.7
120
767
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
6.7
44
191
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.5
6.7
44
191
A02BC02
ATC
pantoprazole; systemic
1.8
6.6
225
1744
R06AE07
ATC
cetirizine; oral
1.8
6.6
154
1067
A02BA02
ATC
ranitidine; systemic
2.0
6.6
78
433
N02AX02
ATC
tramadol; systemic, rectal
1.8
6.5
149
1023
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
6.5
97
584
J38.5
ICD-10 Finland
Laryngeal spasm
71.1
6.4
7
*
A10AB05
ATC
insulin aspart; parenteral
2.6
6.4
37
150
J96.9
ICD-10 Finland
Respiratory failure, unspecified
14.7
6.4
10
7
XG413
NOMESCO Finland
Spirometry with oscillometry
14.7
6.4
10
7
SPAT1255
SPAT
Intravenous administration of medicine
3.1
6.4
27
92
WX702
NOMESCO Finland
Supraglottic ventilation device
3.0
6.4
28
98
R09
ICPC
Sinus symptom/complaint
2.6
6.3
39
164
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.6
6.3
38
158
A41.9
ICD-10 Finland
Sepsis, unspecified
3.8
6.3
19
52
SPAT1257
SPAT
Teaching of medicine inhalation technique
3.8
6.3
19
52
W17
ICD-10 Finland
Other fall from one level to another
3.7
6.3
20
57
UGB02
NOMESCO Finland
Tracheoscopy
27.2
6.3
8
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.1
6.2
66
351
R05FA02
ATC
opium derivatives and expectorants; systemic
1.8
6.2
140
956
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.4
6.2
44
198
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
6.2
47
218
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.0
6.2
28
100
A10AA01, ,
ATC
4.3
6.2
16
39
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
6.1
86
505
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.8
6.1
30
112
J01FA09
ATC
clarithromycin; systemic
1.8
6.1
115
744
WZC30
NOMESCO Finland
Teaching
2.1
6.0
62
325

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
66
38
21.25
82.99
5.2
2.9
—
—
—
0
0
119
181
9.52
80.55
2.1
1.3
96.95
280.48
u/ml
0.75
108
162
96
212
5.89
43.56
4.8
3.2
151.91
225.21
ng/l
1.07
88
190
32
25
14.01
33.60
1.7
1.3
0.29
7.83
u/ml
1.41
26
16
69
145
5.70
32.48
11.7
9.6
—
—
—
0
0
117
389
4.04
30.96
2.3
1.9
—
—
—
0
0
94
310
3.80
24.59
11.4
8.2
2.00
1.15
mmol/l
1.75
85
260
251
1529
3.37
23.02
10.7
6.7
0.20
0.19
e9/l
0.06
237
1333
63
167
4.39
22.14
8.0
4.4
—
—
—
0
0
156
752
2.97
21.35
6.2
4.0
—
—
—
0
0
233
1402
3.05
20.99
11.1
7.1
—
—
—
0
0
229
1376
2.99
20.47
10.9
6.4
0.60
0.68
%
1.36
221
1287
244
1521
3.08
20.32
10.0
6.4
1.88
2.10
e9/l
1.44
233
1348
239
1482
3.01
19.92
9.6
6.3
0.04
0.04
e9/l
0.57
224
1267
221
1320
2.89
19.67
22.7
13.6
1.24
1.25
inr
0.05
47
384
231
1415
2.93
19.54
11.0
6.4
2.75
2.89
%
0.42
224
1326
237
1477
2.94
19.31
9.7
6.3
0.65
0.58
e9/l
3.58
223
1264
231
1422
2.90
19.23
11.9
6.6
8.65
8.55
%
0.22
223
1338
235
1462
2.92
19.13
11.1
6.5
26.68
30.05
%
4.93
228
1379
157
804
2.75
18.57
5.9
3.3
704.86
1418.50
ng/l
4.52
142
675
231
1438
2.85
18.53
10.9
6.3
59.03
55.03
%
5.58
223
1355
258
1719
3.00
17.88
12.4
9.7
4.59
3.97
e9/l
2.80
239
1491
88
336
3.18
17.77
2.0
1.6
—
—
—
0
0
85
318
3.22
17.76
9.2
8.2
2.02
1.74
mmol/l
0.39
72
264
89
344
3.14
17.59
1.7
1.3
—
—
—
0
0
128
611
2.74
17.11
3.5
2.2
1.22
1.21
mg/l
0.01
100
482
228
1472
2.63
15.96
15.7
7.9
1.22
1.22
mmol/l
0.51
203
1263
31
59
5.68
15.92
4.4
3.7
6.68
7.42
mmol/l
0.98
31
59
158
863
2.54
15.77
3.3
2.4
193.89
61.56
u/l
0.46
152
788
61
202
3.46
15.39
1.5
1.4
—
—
—
0
0
28
26
11.62
15.29
1.7
1.1
—
—
—
0
0
161
906
2.46
14.84
4.1
3.2
—
—
—
0
0
226
1487
2.52
14.65
8.1
6.4
13.41
13.83
umol/l
0.09
219
1395
114
551
2.60
14.49
7.1
3.7
65.17
265.08
ng/l
2.90
93
437
54
187
3.24
12.59
1.7
1.9
0.96
1.31
g/l
1.22
49
176
21
35
6.33
12.27
2.5
3.5
—
—
—
0
0
241
1713
2.36
11.95
11.7
5.6
6.88
6.57
mmol/l
1.39
230
1598
189
1222
2.21
11.73
7.3
4.9
34.32
35.62
g/l
2.09
177
1148
23
45
5.41
11.43
1.2
1.2
—
—
—
0
0
31
80
4.16
11.10
6.4
5.0
—
—
—
0
0
21
41
5.39
10.45
2.6
3.6
1.77
1.28
e9/l
0.79
16
28
21
41
5.39
10.45
2.9
2.5
—
—
—
0
0
21
42
5.26
10.18
2.9
2.5
105.38
105.38
mmol/l
-0.00
21
42
21
42
5.26
10.18
2.9
2.5
3.93
3.98
mmol/l
0.19
21
42
271
2094
2.39
10.05
7.6
4.1
13.45
12.08
mm/h
0.79
262
1910
75
349
2.47
9.94
1.7
1.4
1088.57
552.41
titre
0.58
14
79
55
220
2.79
9.88
2.7
3.4
66.43
66.10
g/l
0.12
47
196
135
807
2.11
9.78
2.8
2.0
141.41
234.83
u/l
1.35
124
762
62
267
2.61
9.64
16.0
7.4
7.41
7.42
ph
—
8
22
169
1112
2.02
9.30
5.1
3.6
5.81
6.00
ph
—
8
84
102
560
2.17
9.11
1.9
1.8
77778391.36
464.81
pmol/l
0.49
81
458
23
56
4.33
8.86
1.3
2.0
—
—
—
0
0
52
214
2.68
8.82
3.4
4.4
1.00
0.50
%
0.82
15
77
120
710
2.06
8.76
2.8
2.2
3.23
3.18
mg/l
0.03
105
612
20
44
4.76
8.70
2.4
2.0
—
—
—
0
0
184
1272
1.96
8.55
4.0
2.7
—
—
—
0
0
32
102
3.36
8.47
3.6
1.9
1.28
3.60
ug/l
0.41
26
94
22
56
4.13
8.01
5.1
4.1
—
—
—
0
0
249
1936
2.04
7.94
7.3
4.5
—
—
—
0
0
193
1378
1.91
7.93
5.6
3.9
0.03
0.00
estimate
0.42
29
281
126
786
1.95
7.75
4.3
3.7
9.33
32.05
mg/mmol
0.49
84
492
54
241
2.47
7.74
3.9
4.5
1.23
0.70
%
1.20
15
97
194
1397
1.89
7.66
5.6
3.9
0.00
0.00
estimate
-0.00
22
254
189
1358
1.87
7.43
15.7
7.5
1.20
1.22
mmol/l
2.72
171
1240
81
446
2.07
6.99
2.8
2.4
12.90
13.34
umol/l
0.18
71
410
152
1036
1.84
6.94
6.3
3.8
26.74
38.93
ng/l
1.12
108
739
76
410
2.10
6.92
2.8
2.4
2.36
2.39
g/l
0.19
67
374
37
145
2.74
6.87
6.5
9.0
0.65
0.65
%
0.03
37
145
72
389
2.08
6.51
2.8
2.5
21.36
22.51
%
0.22
50
342
188
1385
1.79
6.48
8.5
5.4
0.00
0.00
estimate
-0.00
23
260
86
497
1.97
6.45
1.7
1.7
869.60
1215.64
nmol/l
4.15
64
359
126
825
1.83
6.45
3.8
3.3
6.57
7.30
mmol/l
1.12
112
694
18
35
5.37
6.41
2.7
3.6
0.36
0.21
e9/l
0.61
13
23
263
2152
1.94
6.37
10.5
7.0
79.35
84.58
u/l
0.87
255
2005
119
770
1.83
6.30
5.4
3.6
—
—
—
0
0
47
216
2.36
6.29
16.5
7.3
—
—
—
0
0
18
36
5.22
6.27
2.6
3.5
641.62
532.74
e6/l
0.35
13
23
12
14
8.83
6.10
1.2
1.8
—
—
—
0
0
46
213
2.34
6.06
3.8
4.7
0.29
0.14
%
—
7
69
167
1208
1.74
5.97
3.6
2.4
80.18
77.54
nmol/l
0.65
153
1065
36
150
2.56
5.94
2.9
2.4
—
—
—
0
0
47
222
2.29
5.91
4.0
4.7
0.11
0.13
%
—
9
78
26
92
2.98
5.81
1.1
1.3
—
3.36
—
0
8
41
184
2.39
5.78
2.6
2.8
—
—
—
0
0
35
146
2.56
5.76
5.5
4.0
—
—
—
0
0
48
232
2.24
5.72
6.0
4.5
70.53
71.08
ng/l
0.02
43
207
114
747
1.79
5.69
3.6
3.0
556.92
228.43
mg/l
0.28
72
479
96
602
1.82
5.53
5.7
4.1
1.02
1.02
kg/l
0.05
24
97
96
612
1.79
5.20
5.1
3.3
533.61
531.13
mosm/kgh2o
0.04
84
521
77
459
1.87
5.18
9.2
4.8
0.85
0.81
mmol/l
0.79
71
433
77
460
1.87
5.14
1.2
1.3
15.89
31.03
iu/ml
1.74
19
147
233
1898
1.71
5.01
5.6
3.8
—
—
—
0
0
11
16
7.06
4.99
1.7
1.1
—
—
—
0
0
37
171
2.30
4.89
19.0
9.0
9.02
8.88
kpa
0.18
37
166
163
1223
1.63
4.74
3.6
2.7
97.52
113.55
ug/l
0.56
152
1120
316
2846
2.36
4.73
35.8
14.1
20.72
23.28
mg/l
1.08
293
2224
149
1095
1.64
4.69
2.2
2.0
96.92
95.79
pmol/l
0.09
77
546
49
259
2.04
4.65
12.4
8.3
8.42
8.04
mmol/l
0.15
43
248
122
854
1.66
4.64
4.3
3.5
7.41
7.40
ph
0.18
15
164
19
64
3.08
4.63
7.9
3.7
—
—
—
0
0
15
38
4.08
4.35
1.1
1.3
—
—
—
0
0
97
649
1.69
4.34
1.8
1.5
2.08
2.24
g/l
0.39
74
361
11
20
5.64
4.32
1.2
1.3
—
—
—
0
0
20
74
2.81
4.16
2.4
5.3
24.36
145.08
mg/l
0.79
15
60
20
74
2.81
4.16
2.5
5.3
34.40
26.36
mg/l
0.24
15
60
12
26
4.74
4.09
3.4
4.2
476.67
533.64
e6/l
—
6
11
105
728
1.64
4.07
2.2
1.7
1.34
1.33
mmol/l
0.05
91
618
70
443
1.73
3.80
1.7
1.8
—
—
—
0
0
45
251
1.91
3.67
3.8
3.9
80.20
70.36
e9/l
0.93
32
185
69
439
1.72
3.67
1.3
1.3
8.62
9.62
u/ml
0.05
26
170
44
244
1.92
3.65
1.5
1.4
—
—
—
0
0
16
57
2.90
3.57
1.6
6.2
—
—
—
0
0
6
6
10.15
3.51
1.0
1.3
—
—
—
0
0
51
301
1.82
3.50
17.2
9.5
—
—
—
0
0
249
2153
1.57
3.40
5.8
3.8
14.86
14.80
pmol/l
0.14
237
1926
97
688
1.57
3.34
3.5
3.0
12807.78
7328.71
umol/l
0.33
83
593
14
48
3.00
3.34
2.4
1.8
—
—
—
0
0
56
347
1.73
3.26
5.0
3.8
1.79
1.70
%
0.35
48
314
41
231
1.88
3.26
3.0
2.3
5.86
5.41
ug/l
0.12
32
205
94
670
1.55
3.15
1.6
1.5
23.57
21.61
nmol/l
0.44
79
561
271
2412
1.58
3.03
42.9
18.6
331.77
332.12
g/l
0.23
271
2398
9
22
4.17
2.90
1.2
1.0
—
—
—
0
0
7
13
5.47
2.88
4.3
5.0
—
—
—
0
0
53
338
1.67
2.79
6.3
3.3
6.58
8.37
umol/l
0.39
46
290
285
2586
1.60
2.72
7.0
4.6
1.95
2.41
mu/l
0.48
272
2349
115
879
1.46
2.72
4.1
2.5
—
—
—
0
0
5
7
7.23
2.55
1.0
1.4
—
—
—
0
0
5
8
6.32
2.38
15.4
3.5
—
—
—
0
0
7
17
4.18
2.37
1.3
1.2
—
—
—
0
0
6
13
4.68
2.28
1.2
1.2
—
—
—
0
0
86
644
1.45
2.21
4.8
3.7
—
—
—
0
0
55
376
1.55
2.19
1.5
1.2
—
—
—
0
0
69
497
1.49
2.16
4.9
3.4
3.85
2.83
e6/l
0.30
48
265
8
25
3.25
2.10
1.6
1.2
—
—
—
0
0
18
89
2.08
2.10
1.8
1.3
304.45
295.58
ug/g
0.08
11
52
310
2911
1.66
2.10
30.8
12.8
—
—
—
0
0
117
934
1.38
2.09
5.2
3.6
13.68
109.19
e6/l
0.76
95
708
16
76
2.16
2.06
1.3
1.2
3.96
3.17
u/ml
0.08
11
56
269
2460
1.43
2.00
8.5
5.7
41.44
39.90
mmol/mol
1.72
253
2283
160
1350
1.35
1.99
16.0
10.3
0.00
0.00
e9/l
0.47
142
1081
7
21
3.38
1.97
1.4
1.2
—
—
—
0
0
102
803
1.38
1.97
7.2
3.9
—
—
—
0
0
43
285
1.58
1.97
1.6
1.5
—
—
—
0
0
281
2598
1.45
1.89
5.7
4.5
5.92
5.94
mmol/l
0.08
264
2353
55
389
1.49
1.89
2.1
2.3
115.95
105.80
ug/g
0.15
44
306
44
297
1.55
1.87
1.6
1.7
—
—
—
0
0
36
232
1.62
1.85
3.5
3.8
1.25
1.23
mmol/l
0.45
31
203
41
273
1.57
1.85
3.0
2.6
0.22
0.21
g/l
0.09
41
259
38
249
1.59
1.83
1.2
1.2
—
—
—
0
0
278
2571
1.42
1.82
5.3
4.4
1.44
1.50
mmol/l
1.49
256
2355
269
2475
1.40
1.80
4.5
4.0
1.30
1.27
mmol/l
0.35
250
2255
23
377
0.58
1.74
2.7
3.0
0.76
0.72
ug/l
0.04
14
246
8
30
2.71
1.73
6.0
2.6
16.99
36.73
mu/l
—
8
30
19
105
1.86
1.66
1.7
1.7
—
—
—
0
0
19
105
1.86
1.66
6.3
5.2
—
—
—
0
0
26
161
1.67
1.58
1.4
1.2
—
—
—
0
0
14
71
2.01
1.56
1.2
1.2
0.82
1.47
u/ml
—
7
51
311
2958
1.54
1.55
16.7
10.3
25.28
25.19
u/l
0.04
302
2839
28
178
1.62
1.54
1.3
1.2
96.27
181.07
iu/ml
0.94
11
60
28
178
1.62
1.54
1.0
1.3
—
34.52
—
0
12
326
3136
1.76
1.54
47.5
21.3
37.93
39.67
%
2.44
271
2963
278
2593
1.38
1.53
5.4
4.5
4.42
4.65
mmol/l
3.08
260
2387
89
714
1.33
1.49
1.4
1.4
0.63
1.74
u/ml
1.45
22
161
9
38
2.40
1.46
1.6
1.4
—
—
—
0
0
14
73
1.96
1.46
1.2
1.2
4.96
6.65
u/ml
—
9
56
37
256
1.50
1.43
1.6
1.7
—
—
—
0
0
13
67
1.98
1.40
1.2
2.9
—
—
—
0
0
11
53
2.11
1.40
4.1
3.2
56.64
56.66
%
0.00
11
53
5
17
2.97
1.36
4.6
1.9
—
—
—
0
0
281
2640
1.35
1.36
6.0
5.0
2.48
2.73
mmol/l
4.82
255
2411
12
61
2.00
1.34
3.8
3.0
—
—
—
0
0
12
215
0.54
1.28
1.2
1.4
—
—
—
0
0
8
35
2.32
1.27
1.1
1.7
—
—
—
0
0
19
115
1.69
1.27
3.4
5.5
0.07
0.30
g/l
—
5
51
40
541
0.71
1.27
2.5
2.8
2.46
2.46
mmol/l
0.04
35
479
6
25
2.42
1.25
1.3
1.2
—
—
—
0
0
6
25
2.42
1.25
1.2
3.3
—
—
—
0
0
5
20
2.52
1.15
3.6
2.7
23.60
27.75
umol/l
—
5
20
12
65
1.88
1.15
3.4
1.6
—
—
—
0
0
10
51
1.99
1.12
4.0
2.8
4.59
4.54
e9/l
—
10
51
16
96
1.70
1.12
1.6
1.2
—
—
—
0
0
123
1065
1.24
1.11
7.0
4.3
45.56
76.74
e6/l
0.54
96
750
5
21
2.40
1.09
1.2
1.4
—
—
—
0
0
7
32
2.21
1.08
1.3
1.1
—
—
—
0
0
7
32
2.21
1.08
4.9
3.1
12.07
16.31
ug/l
—
7
32
41
308
1.38
1.06
3.2
4.0
5.09
44.29
ug/l
0.89
33
256
100
851
1.25
1.05
4.7
3.5
0.15
0.50
e6/l
2.84
82
626
5
23
2.19
0.98
2.4
2.7
—
—
—
0
0
91
774
1.24
0.96
9.4
7.0
—
—
—
0
0
6
27
2.24
0.94
2.5
2.9
—
—
—
0
0
86
730
1.24
0.92
6.2
4.1
0.00
0.00
estimate
-0.00
23
256
13
79
1.67
0.89
2.1
1.5
264.92
341.32
mu/l
0.52
13
74
26
187
1.42
0.88
2.9
2.7
—
—
—
0
0
8
43
1.88
0.88
1.4
1.6
—
—
—
0
0
8
141
0.56
0.84
1.6
1.4
—
—
—
0
0
17
114
1.52
0.81
1.1
1.2
—
—
—
0
0
6
33
1.83
0.79
1.0
1.0
171.50
163.27
g/l
—
6
33
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
45
362
1.28
0.77
1.6
1.5
—
—
—
0
0
7
38
1.86
0.74
1.1
1.1
—
—
—
0
0
10
60
1.69
0.73
2.2
3.5
12.80
30.31
u/ml
—
10
60
10
60
1.69
0.73
2.3
1.9
90.90
231.83
u/ml
—
5
23
11
68
1.64
0.72
21.2
14.4
—
—
—
0
0
7
40
1.77
0.71
1.1
2.1
—
—
—
0
0
73
629
1.20
0.68
3.8
2.8
3.94
6.33
e6/l
0.97
62
565
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
6
35
1.73
0.58
1.0
1.0
—
—
—
0
0
6
37
1.63
0.56
1.7
1.2
—
—
—
0
0
6
40
1.51
0.52
3.8
4.9
—
—
—
0
0
7
48
1.47
0.47
1.9
1.4
—
—
—
0
0
12
86
1.41
0.45
4.4
3.1
—
—
—
0
0
5
31
1.62
0.43
1.0
1.3
—
—
—
0
0
5
32
1.57
0.42
1.0
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
9
69
1.31
0.37
1.2
1.1
—
—
—
0
0
6
42
1.44
0.35
2.3
1.5
—
—
—
0
0
6
88
0.68
0.33
3.5
1.5
—
—
—
0
0
6
88
0.68
0.33
3.5
1.5
—
—
—
0
0
6
88
0.68
0.33
3.5
1.5
—
—
—
0
0
6
89
0.67
0.33
3.5
1.5
—
—
—
0
0
6
47
1.28
0.32
2.2
1.2
—
—
—
0
0
7
52
1.35
0.31
3.7
1.7
252.71
213.13
pmol/l
—
7
46
25
213
1.19
0.30
3.1
3.4
—
—
—
0
0
7
57
1.23
0.29
1.0
1.0
—
—
—
0
0
11
85
1.30
0.28
1.9
2.2
13734.62
5233.87
u/l
—
6
30
21
177
1.20
0.28
1.4
1.4
—
—
—
0
0
88
826
1.09
0.25
5.0
3.4
—
—
—
0
0
31
274
1.14
0.25
2.5
2.3
24.28
30.81
u/l
1.22
25
233
6
83
0.72
0.24
3.5
1.5
—
—
—
0
0
5
41
1.22
0.22
4.2
5.8
8.56
6.08
mmol/l
—
5
34
80
753
1.08
0.22
1.5
1.4
—
—
—
0
0
13
107
1.22
0.22
1.2
1.1
—
—
—
0
0
5
42
1.19
0.21
1.2
3.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
136.06
—
0
11
0
10
0.00
0.21
0.0
16.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
59.40
—
0
10
0
10
0.00
0.21
0.0
1.0
—
1148.70
—
0
10
8
105
0.76
0.21
1.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
3.0
—
4.38
—
0
12
0
12
0.00
0.21
0.0
4.9
—
—
—
0
0
28
313
0.89
0.21
1.4
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
113
1083
1.06
0.19
2.1
2.1
—
—
—
0
0
6
52
1.16
0.19
1.2
1.1
—
—
—
0
0
6
52
1.16
0.19
1.2
1.1
—
—
—
0
0
24
213
1.14
0.19
1.8
1.7
—
—
—
0
0
69
651
1.07
0.18
5.5
5.0
7.25
2.02
ug/l
0.44
63
571
29
263
1.11
0.17
2.0
1.4
—
—
—
0
0
5
68
0.73
0.17
1.2
1.6
—
—
—
0
0
102
979
1.06
0.16
3.5
3.2
2.32
2.37
mmol/l
1.96
91
874
8
70
1.15
0.16
1.0
1.0
7.95
7.71
mu/l
—
8
70
6
79
0.76
0.15
19.5
10.4
—
—
—
0
0
37
343
1.09
0.15
1.0
1.3
—
—
—
0
0
88
917
0.95
0.15
4.7
2.9
—
—
—
0
0
8
100
0.80
0.13
2.1
1.9
—
—
—
0
0
24
259
0.92
0.10
5.3
4.2
—
—
—
0
0
19
175
1.09
0.08
1.1
1.3
—
—
—
0
0
5
65
0.77
0.08
6.0
1.6
—
—
—
0
0
25
238
1.05
0.05
5.7
4.0
—
—
—
0
0
10
92
1.09
0.03
1.6
1.6
—
—
—
0
0
12
113
1.06
0.02
1.4
1.9
—
—
—
0
0
10
95
1.05
0.00
1.5
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
18.5
—
0.66
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
6.15
—
0
5
0
7
0.00
-0.00
0.0
2.0
—
4.26
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
17.76
—
0
7
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
9
94
0.96
-0.00
4.9
2.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
8.3
—
6.87
—
0
9
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_MALFO_TRACHEA_BRONCHUS and mortality.

Females

Parameter HR [95% CI] p-value
Q17_CONGEN_MALFO_TRACHEA_BRONCHUS 1.555 [1.29, 1.87] < 0.001
Birth year 0.996 [0.99, 1.0] 0.321

During the follow-up period (1.1.1998 — 31.12.2019), 247 out of 1161 females with Q17_CONGEN_MALFO_TRACHEA_BRONCHUS died.

Males

Parameter HR [95% CI] p-value
Q17_CONGEN_MALFO_TRACHEA_BRONCHUS 1.684 [1.38, 2.06] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 213 out of 1065 males with Q17_CONGEN_MALFO_TRACHEA_BRONCHUS died.

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_MALFO_TRACHEA_BRONCHUS.

N-year risk Females Males
1 0.15% 0.306%
5 1.047% 1.854%
10 2.408% 4.856%
15 4.395% 9.008%
20 7.683% 14.552%

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_MALFO_TRACHEA_BRONCHUS – Congenital malformations of trachea and bronchus

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data